首頁 > 市場調查報告書 > 醫療設備

骨骼生長刺激器市場規模、佔有率及成長分析（按材質、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900614

骨骼生長刺激器市場規模、佔有率及成長分析（按材質、應用、最終用戶和地區分類）－2026-2033年產業預測

Bone Growth Stimulators Market Size, Share, and Growth Analysis, By Material Type (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球骨骼生長刺激器市場規模預計在 2024 年達到 29.6 億美元，從 2025 年的 31.3 億美元成長到 2033 年的 48.3 億美元，在預測期（2026-2033 年）內複合年成長率為 5.6%。

骨骼生長促效劑作為一種輔助治療方法，在促進癒合方面需求日益成長，尤其適用於難以自然癒合的骨折。全球骨折和運動傷害發病率的不斷上升是推動該市場發展的主要因素。脊髓損傷也顯著增加了對有效治療方法的需求，每年影響眾多患者。骨生長刺激技術和產品已被證明在包括整形外科、牙科和骨折修復在內的多個領域都具有很高的應用價值。骨關節炎和退化性疾病的高發生率進一步支撐了該市場的發展。此外，富血小板血漿（PRP）和骨形成蛋白（BMP）在治療效果方面的進步預計將推動該領域未來的成長。

推動全球骨骼生長刺激器市場發展的因素

整形外科疾病（包括骨折、骨延遲癒合、骨不連和骨質疏鬆相關損傷）發生率的不斷上升，是骨生長刺激器市場的主要驅動力。隨著人口老化相關疾病和整形外科問題的日益增多，對有效治療方法的需求也隨之成長。醫療專業人員致力於應對這些普遍存在的患者照護挑戰，因此，對促進骨骼癒合和再生的創新解決方案的需求不斷成長，推動了骨生長刺激器技術的進步。預計這些刺激器的市場將顯著擴大。

限制全球骨骼生長刺激器市場的因素

全球骨骼生長刺激器市場面臨一些限制因素，主要與使用過程中存在的風險和副作用有關。雖然這些設備通常被認為是安全的，但仍可能引起皮膚刺激、過敏反應和治療過程中的不適等問題。這些潛在的不良反應引起了患者和醫療保健提供者的擔憂，可能導致他們不願意採用這些技術。隨著越來越多的人選擇風險較低的替代療法和治療方法，這種擔憂可能會阻礙市場成長，從而影響骨骼生長刺激器的整體市場需求和接受度。

全球骨骼生長刺激器市場趨勢

全球骨生長刺激器市場正經歷顯著的變革，這主要得益於非侵入性治療方法方案的拓展。患者和醫療專業人員擴大選擇骨骼生長刺激器，它為脊椎融合手術和骨折等疾病提供了比傳統手術更人性化的替代方案。這一趨勢反映了人們對微創技術的廣泛需求，這些技術能夠促進癒合和康復，同時最大限度地降低風險和不適感。此外，技術的進步以及人們對這些設備益處的日益了解也促進了其廣泛應用，骨生長刺激器正逐漸成為現代整形外科治療的重要組成部分。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Orthofix Holdings, Inc.（USA）
Medtronic plc（Ireland）
Zimmer Biomet Holdings, Inc.（USA）
Stryker Corporation（USA）
Terumo Corporation（Japan）
Bioventus LLC（USA）
Igea SpA（Italy）
Ossatec AS（Norway）
Biotronik SE & Co. KG（Germany）
DJO Global, Inc.（USA）
EMS Physio Ltd.（UK）
Orthocell Ltd.（Australia）
Altis Biologics（South Africa）
ISTO Biologics（USA）
Regenlab SA（Switzerland）
Exactech, Inc.（USA）
Collagen Matrix, Inc.（USA）
ATEC, Inc.（USA）

結論與建議

簡介目錄

Product Code: SQMIG35A2314

Global Bone Growth Stimulators Market size was valued at USD 2.96 Billion in 2024 and is poised to grow from USD 3.13 Billion in 2025 to USD 4.83 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).

The demand for bone growth stimulators is on the rise as they serve as a complementary therapy for enhancing the healing of fractures, particularly those resistant to natural recovery. The increasing incidence of bone fractures and sports injuries globally is a key driver of this market. Spinal cord injuries also contribute significantly to the need for effective treatment options, impacting numerous individuals yearly. Bone growth stimulation technologies and products are proving invaluable across various fields, including orthopedics, dentistry, and fracture repair. The market is further supported by the prevalence of osteoarthritis and degenerative bone diseases. Additionally, advancements in healing outcomes through the use of platelet-rich plasma and bone morphogenetic proteins are expected to propel future growth in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bone Growth Stimulators market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bone Growth Stimulators Market Segments Analysis

Global Bone Growth Stimulators Market is segmented by Material Type, Application, End User and region. Based on Material Type, the market is segmented into Bone Growth Stimulation Devices, Bone Morphogenetic Proteins and Platelet-Rich Plasma. Based on Application, the market is segmented into Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries and Other Applications. Based on End User, the market is segmented into Hospitals and Ambulatory Surgical Centers, Home Care Settings and Academic and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bone Growth Stimulators Market

The increasing incidence of orthopedic disorders, including fractures, delayed unions, non-unions, and osteoporosis-related injuries, serves as a major catalyst for the bone growth stimulators market. With a larger segment of the population experiencing age-related conditions and related orthopedic issues, there is a corresponding surge in the need for effective treatment options. This growing demand for innovative solutions to enhance bone healing and regeneration is driving advancements in bone growth stimulators, as healthcare providers seek to address these prevalent challenges in patient care. Consequently, the market for these stimulators is poised for significant expansion.

Restraints in the Global Bone Growth Stimulators Market

The Global Bone Growth Stimulators market faces certain restraints primarily due to the associated risks and side effects linked to their use. Although these devices are predominantly deemed safe, they can cause issues such as skin irritation, allergic reactions, and discomfort during treatment. Such potential adverse effects may raise concerns among patients and healthcare providers alike, leading to hesitation in adopting these technologies. This apprehension can hinder market growth, as individuals may opt for alternative therapies or treatments that are perceived as carrying fewer risks, thereby impacting overall market demand and acceptance of bone growth stimulators.

Market Trends of the Global Bone Growth Stimulators Market

The Global Bone Growth Stimulators market is experiencing a significant shift driven by the growing preference for non-invasive treatment options. Patients and healthcare professionals are increasingly gravitating towards bone growth stimulators, which offer a more patient-friendly alternative to traditional surgical interventions for conditions such as spinal fusion and fractures. This trend reflects a broader demand for less intrusive methods that enhance healing and recovery while minimizing risks and discomfort. Additionally, advancements in technology and increased awareness of these devices' benefits are contributing to their rising adoption, positioning bone growth stimulators as a vital component of modern orthopedic care.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Bone Growth Stimulators Market Size by Material Type & CAGR (2026-2033)

Market Overview
Bone Growth Stimulation Devices
- External Bone Growth Stimulators
- Ultrasonic Bone Growth Stimulators
- Implanted Bone Growth Stimulators
Bone Morphogenetic Proteins
Platelet-Rich Plasma

Global Bone Growth Stimulators Market Size by Application & CAGR (2026-2033)

Market Overview
Spinal Fusion Surgeries
Delayed Union & Nonunion Bone Fractures
Oral & Maxillofacial Surgeries
Other Applications

Global Bone Growth Stimulators Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals and Ambulatory Surgical Centers
Home Care Settings
Academic and Research Institutes

Global Bone Growth Stimulators Market Size & CAGR (2026-2033)

North America (Material Type, Application, End User)
- US
- Canada
Europe (Material Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Material Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Material Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Material Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Orthofix Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Igea S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ossatec AS (Norway)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DJO Global, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EMS Physio Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthocell Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altis Biologics (South Africa)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ISTO Biologics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regenlab SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exactech, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Collagen Matrix, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATEC, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments